Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-17

Clinical Trial Update: Efficacy of Rostafuroxin in the Treatment of Essential Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rostafuroxin for essential hypertension has completed; the update summarizes the efficacy findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rostafuroxin (rostafuroxin)

Snippet

Sponsor: sigma-tau i.f.r. S.p.A. | Conditions: Essential Hypertension | Phase 2 | Status: COMPLETED